The trademark application A-KINE was filed by Orionis Biosciences Inc., a U.S. corporation (the "Applicant"). The application was published for oppositions on September 30, 2020, and it was registered by office on January 12, 2021 without any oppositions.
The application was filed in English (French was selected as the second language).
Appointment and Replacement of representative of the trademark registration was recorded on January 6, 2021. Appointment and Replacement of representative of the trademark registration was recorded on February 1, 2021.
Goods And Services
The mark was filed in class 1 with following description of goods:
Cytokines, namely, reagents for scientific and research
Diagnostic and biological reagents for scientific and research use
Pharmaceutical intermediates for use in the further manufacture of pharmaceuticals
Active chemical ingredients for use in the manufacture of pharmaceuticals for treating cancer, auto immune diseases, metabolic diseases, neurological diseases, neuromuscular diseases.
The mark was filed in class 5 with following description of goods:
Pharmaceutical products, serums and preparations for the treatment of cancer, auto immune disorders, metabolic disorders
Therapeutic pharmaceutical and diagnostic preparations, namely, antibodies, cytokines, antigens, enzymes, immunoconjugates for treatment of cancer, immunological conditions, metabolic disorders
Biochemical preparations for medical purposes for use in the treatment of cancer, auto immune diseases, metabolic diseases.
The mark was filed in class 42 with following description of goods:
Development of new technology for others in the field of biotechnology
Scientific research and laboratory research services in the medical, bacteriological and biotechnical fields
Biotechnical research
Technical consultation and research in the field of biotechnological research
Consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenetics
Research and development of pharmaceuticals for others
Scientific and medical research in the fields of oncology, immunology and immune-oncology, inflammation, immune-mediated diseases, protein homeostasis, epigenetics and protein metabolism.